RHUMBLINE ADVISERS

Position in TRDA — Entrada Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in TRDA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$270,428

-$183,109 QoQ

Shares Held

36,743

+2.2% QoQ

Ownership

0.094%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#57

of 128 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 16% Shared 0% None 84%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. TRDA ranks #223 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$270,428	36,743	+2.2%	Shares	Sole	2026-08-12
2026-03-31	$453,537	35,938	-0.8%	Shares	Sole	2026-05-12
2025-12-31	$372,372	36,223	-8.1%	Shares	Sole	2026-02-13
2025-09-30	$228,682	39,428	+0.9%	Shares	Sole	2025-11-06
2025-06-30	$262,718	39,095	+8.3%	Shares	Sole	2025-08-12
2025-03-31	$326,461	36,113	-1.7%	Shares	Sole	2025-05-29
2024-12-31	$635,078	36,731	+1.2%	Shares	Sole	2025-05-29
2024-09-30	$580,042	36,298	-1.7%	Shares	Sole	2024-11-12
2024-06-30	$526,395	36,940	+25.3%	Shares	Sole	2024-08-01
2024-03-31	$417,844	29,488	+3.5%	Shares	Sole	2024-05-09
2023-12-31	$429,944	28,492	+7.7%	Shares	Sole	2024-02-08
2023-09-30	$417,894	26,449	+9.2%	Shares	Sole	2023-11-09
2023-06-30	$366,675	24,219	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.